~~<i id='C787392257'><strike id='C787392257'><tt id='C787392257'><pre id='C787392257'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：leisure time 2025-09-27 14:42:26 Page View：477

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： No plane should take off without an EpiPen onboard
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

comprehensive

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Scientists inch closer to single

AdobeWhatisthebestwaytofixfaultybloodcells,anddosoforthemostpeople?That’sthequestionahordeofgeneedit

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

BraziliansoccerplayerNeymarwatchesduringthefirsthalfofGame4ofthebasketballNBAFinalsbetweentheMiamiHe